Rise of the SARS-CoV-2 Variants: can proteomics be the silver bullet?


Journal article


Arup Acharjee, Joshua Stephen Kingsly, Madhura Kamat, Vishakha Kurlawala, Aparajita Chakraborty, Priyanka Vyas, Radhika Vaishnav, Sanjeeva Srivastava
Expert Review of Proteomics, Taylor \& Francis, 2022

Cite

Cite

APA   Click to copy
Acharjee, A., Kingsly, J. S., Kamat, M., Kurlawala, V., Chakraborty, A., Vyas, P., … Srivastava, S. (2022). Rise of the SARS-CoV-2 Variants: can proteomics be the silver bullet? Expert Review of Proteomics.


Chicago/Turabian   Click to copy
Acharjee, Arup, Joshua Stephen Kingsly, Madhura Kamat, Vishakha Kurlawala, Aparajita Chakraborty, Priyanka Vyas, Radhika Vaishnav, and Sanjeeva Srivastava. “Rise of the SARS-CoV-2 Variants: Can Proteomics Be the Silver Bullet?” Expert Review of Proteomics (2022).


MLA   Click to copy
Acharjee, Arup, et al. “Rise of the SARS-CoV-2 Variants: Can Proteomics Be the Silver Bullet?” Expert Review of Proteomics, Taylor \& Francis, 2022.


BibTeX   Click to copy

@article{acharjee2022a,
  title = {Rise of the SARS-CoV-2 Variants: can proteomics be the silver bullet?},
  year = {2022},
  journal = {Expert Review of Proteomics},
  publisher = {Taylor \& Francis},
  author = {Acharjee, Arup and Kingsly, Joshua Stephen and Kamat, Madhura and Kurlawala, Vishakha and Chakraborty, Aparajita and Vyas, Priyanka and Vaishnav, Radhika and Srivastava, Sanjeeva}
}


Share
Tools
Translate to